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2ABSTRACT
Genes coding for DNA polymerases η, ι and ζ, or for both Pol η and Pol ι have been inactivated
by homologous recombination in the Burkitt's lymphoma BL2 cell line, thus providing for the
first time the total suppression of these enzymes in a human context. The UV sensitivities and
UV-induced mutagenesis on an irradiated shuttle vector have been analyzed for these deficient
cell lines. The double Pol η/ι deficient cell line was more UV sensitive than the Pol η-deficient
cell line and mutation hotspots specific to the Pol η-deficient context appeared to require the
presence of Pol ι, thus strengthening the view that Pol ι is involved in UV damage translesion
synthesis and UV-induced mutagenesis. A role for Pol ζ in a damage repair process at late
replicative stages is reported, which may explain the drastic UV-sensitivity phenotype observed
when this polymerase is absent. A specific mutation pattern was observed for the UV-irradiated
shuttle vector transfected in pol ζ-deficient cell lines, which, in contrast to mutagenesis at the
HPRT locus previously reported, strikingly resembled mutations observed in UV-induced skin
cancers in humans. Finally, a Pol η PIP-box mutant (without its PCNA binding domain) could
completely restore the UV resistance in a Pol η deficient cell line, in the absence of UV-induced
foci, suggesting, as observed for Pol ι in a Pol η-deficient background, that TLS may occur
without the accumulation of microscopically visible repair factories.
INTRODUCTION
Prokaryotic and eukaryotic cell division implies faithful semi-conservative replication of
DNA. On damaged DNA, the replication fork will possibly arrest and call upon a set of specific
polymerases whose role is to bypass these lesions so that replication can resume [1].
In humans, ten non-replicative polymerases have been found so far. Among them are the
homologues of the yeast Pol ζ along with Rev1, and two homologues of the yeast RAD30 gene
products, Pol η and Pol ι. Because there are many TLS polymerases in higher eukaryotes, which have
most probably been selected for their mutation avoidance properties, it became attractive to think in
3term of cognate interactions [2]. In such a hypothesis, which is supported by several in vitro and in
vivo experiments, each TLS polymerase, alone or with a partner, could bypass a specific group of
lesions in an error-free mode.
Exposure of cells to UVC and UVB radiations induces covalent bounds between adjacent
pyrimidines, mainly cis-syn cyclobutane pyrimidines dimers (CPDs) and less frequently pyrimidine-
pyrimidone photoproducts ((6-4) PP). In vitro, human Pol η copies CPD T-T dimers like a normal
pair of Ts [3, 4] while it is mutagenic opposite the first T of a (6-4) photoproduct and requires Pol ζ to
extend from this nucleotide [5] Conversely, Pol ι can insert an A opposite the 3’ T of a (6-4)
photoproduct while conflicting data have been reported concerning the bypass of CPDs. Two different
reports concluded in the inability of Pol iota to cope with such a lesion [6, 7] while the group of R.
Woodgate described that Pol iota can perform a mutagenic bypass of CPD [8]. The discrepancies
observed between these studies may be in part explained by the differences in the substrate used,
notably the nucleotidic sequence surrounding the CPD [9].
The cognate proposition for TLS polymerases was formulated following the in vivo situation
provided by the variant form of the xeroderma pigmentosum (XPV) syndrome. In these patients who
display a deficiency in Pol η, there is, despite the presence of a proficient nucleotide excision repair,
an increased incidence of UV-induced skin cancers [10, 11]. The best explanation being so far is that
another polymerase replaces Pol η in its bypass function but this time in a mutagenic mode.
Yeast Rev3 mutants were isolated based on their deficiency in UV-induced mutagenesis. The
REV3L gene was found to encode the catalytic subunit of Pol ζ [12] in association with Rev7. It was
demonstrated that REV3L was also linked to UV-induced mutagenesis in human cells [12] and UV
resistance in avian cells [13]. Strikingly, the human and mouse homologues of Rev3 are twice the size
of the yeast protein with a large domain of 1500 amino acids without any homology with yeast Rev3.
Inactivation of the Rev3l gene in the mouse results in early embryonic lethality, thus suggesting other
functions for this enzyme beyond TLS [14-16]. Despite the data collected using purified yeast Rev3
enzyme, the functions of the human and murine REV3L protein remain speculative.
After UV irradiation, Pol ι is targeted to stalled replication forks in association with Pol η and
PCNA [17] but there are conflicting data on its role in vivo. In a human cell line in which Pol ι
expression was down-regulated by siRNA expression, replication of a UV-irradiated shuttle vector
4did not reveal any obvious role for this polymerase in TLS and mutagenesis [18]. Pol ι/Pol η double-
deficient mice have been analyzed recently by two different groups [19, 20]. In both studies, Pol ι
seemed to play a role in the onset of UV-induced skin cancers.
Despite the large number of data obtained mainly from in vitro experiments, it remains
difficult at this stage to assign a precise role for each TLS polymerase in vivo. Moreover, species
differences in DNA repair processes and polymerases functions may preclude extending the mouse
results to the human situation. By studying human Burkitt’s lymphoma BL2 cells in which either Pol
η, Pol ι, Pol ζ or both Pol η and Pol ι have been inactivated by homologous recombination, we have
been able to collect information on the UV sensitivity and TLS specificities of these different
enzymes. This analysis unravels some unique bypass specificities of human Pol ζ and underlines in
precise sequence contexts the mutagenic role of Pol ι in a Pol η-deficient background.
EXPERIMENTAL PROCEDURES
Cell line and culture conditions
The type I Burkitt's lymphoma BL2 cell lines were cultured in RMPI 1640 with glutamax (Invitrogen,
Carlsbad, CA), supplemented with 10% FCS (Hyclone, Logan, UT) and 100 U/ml penicillin and
streptomycin (Invitrogen). The parental BL2 cell line carries the variant cMYC-IgL translocation of
Burkitt’s lymphomas, and has a deficient p53 pathway due to overexpression of its inhibitor, Mdm2
[21].
Inactivation of POLH and REV3L in the BL2 cell line.
All gene inactivations were carried out by transfection of a pBSK vector containing the 5’ and 3’ gene
homologous sequences flanking the antibiotic resistance cassette. Recombination arms (between 2.45
and 3.45 kb) were obtained by amplification of BL2 cells genomic DNA with Pfu polymerase
(Stratagene, La Jolla, CA). S-Blasticidin (from pcDNA6/TR), zeocin (from pcDNA4/TO) and
histidinol (from pREP 8) resistance genes were cloned from the Invitrogen corresponding plasmids.
They were under the control of the SV40 promoter. Hygromycin resistance was driven by a CMV
promoter and neomycin resistance by the promoter of the phospho-glycerol kinase gene (pgk).
Constructs are detailed in fig.1. 107 cells were electroporated with 25 µg of linearized targeting vector
5and clones selected in 96-wells plates with the appropriate selective agent: G418, 1.5 mg/ml;
hygromycin, 350 µg/ml ; zeocin 500 µg/ml; blasticidin, 5 µg/ml; histidinol, 250 µg/ml (all from
Invitrogen, except histidinol from Sigma Aldrich). The targeting frequency is around 1% for the first
allele and between 0.3 and 0.5 % for the second allele.
Primers used to check homologous recombination at the P O L H  locus are: 3’-KO-eta
ACCTGCTTTCTAGTGTCCAG which is located in 3’ downstream from the construct and the
following primers for each resistance tested: blasti-rev: TTAGCCCTCCCACACATAAC; neo-rev:
CACGGGTAGCCAACGC; zeo-rev: CCACGAAGTGCACGCAGTTG and hygro-rev:
GGCGAGTACTTCTACACAGC. Primers used to check homologous recombination at the REV3L
locus: 3’-KO-zeta-1: GCTGTGCTTCAGTGAAGTAC with a hygro-fwd primer
GCTGTGTAGAAGTACTCGCC (1st allele) and 3’-KO-zeta-2: CTGTCTATAGGCGGCTTGTG
with the neo-rev (2nd allele). Both primers are located in 3’ downstream from the construct. K.O.
clones were regularly checked to be negative for the amplification of the targeted exons. Pol ι:
forward TTCATGATCAAGTGTTGCCC and reverse CTGCCGACTACACTATTCTC. Pol η:
forward ATGGTAACACAGTGGCACTG and reverse GACCACAGATGCCATCATTC. REV3L:
forward ACAGCAGCCAGAAAGCTATC and reverse GAATGTAACTTCCACATGGGC.
The absence of the REV3L mRNA was checked by RT-PCR (see supplementary fig.1B) using a
forward primer located in exon 5 upstream of ATG initiator codon CTTTCTCAGATGGCATTCAG,
and a reverse primer located in exon 6 TTTCGGAACTTGACAGCAGC.
EGFP-Pol η constructs and expression
pTet-tTAK-zeo encoding the tetracycline regulated transactivator (gift of T. Honjo) was transfected in
the Pol ι and REV3L-deficient BL2 cell lines and pTet-tTAK-neo was transfected in a POLH-/- cell
line. Wild-type BL2 transfected with pTet-tTAK-zeo was kindly given by T. Honjo. The EGFP was
fused to the C-terminal part of Pol η, using pEGFP-C1 vector (Clontech, Mountain View, CA). The
EGFP-Pol η  fusion protein was cloned into the tetracycline inducible pBI expression vector
(Clontech) in which a blasticidin resistance cassette (from pcDNA6/TR, Invitrogen) had been inserted
in the Aat II site and the vector obtained was transfected in all transactivated cell lines.
Mutations in the coding sequence of Pol η were generated by PCR mutagenesis on Pol η sequence
cloned in pEGFP-C1. The following underlined amino acids were substituted with alanines in the
6PIP-box mutant EGFP-Pol η: 702-708: QILESFF. The EGFP-Pol η PIP-box mutant was then cloned
in the pIRES puro expression vector. The puromycin is used for selection of transfectants at 350
µg/ml.
UV survival curves and killing assays
2x105 cells were washed and taken in a 100 µl PBS drop, then irradiated with either UVB or UVC
light. UVC light (254 nm) was emitted by a germicidal lamp at a fluence rate of 1 J/m_/s and UVB
light (312 nm) was produced by a Bio-sun device (Vilbert Lourmat, Marne-la-Vallée, France) at a
fluence rate of 8.3 J/m_/s. After irradiation, cells were incubated for 5 days in complete medium and
living cells were counted using Vi-cell XR device (Beckman Coulter, Fullerton, CA).
EGFP-Pol η foci formation after UVC irradiation
EGFP-Pol η positive cells were irradiated using a germicidal lamp at 10 J/m_ at a fluence rate of 1
J/m_/s in 50 µl PBS drops and grown after irradiation in 5 ml of complete medium. Cells were plated
after 8 h to 12 h on glass slides using a Cytospin 2 device (Shandon, Waltham MA) prior to fixation
with methanol for 10 min at room temperature. Slides were mounted with vectashield® (Abcys, Paris,
France) and examined using an Axiovert 200M confocal microscope (Zeiss, Thornwood, NY).
Cell cycle analysis
Cell cycle determination was performed by double staining with propidium iodide (PI) and
Bromodeoxyuridine (BrdU). All washing steps were performed with PBT (PBS, BSA 0.5%, Tween
20 0.1%). BrdU 40 µM (Sigma, St Louis, MO) was added to 106 cells for 4 h, cells were washed and
fixed overnight in 100 µl 70 % ethanol at -20°C. After fixation, DNA was denatured (1ml HCl 2N,
Triton® X-100 0.1%) during 20 min at room temperature. Neutralization was performed with sodium
tetraborate 0.15 M pH 8.5 during 2 min at room temperature. The anti BrdU FITC antibody was
diluted 1/20 (Alexis Biochemicals, San Diego, CA) and incubated with cells for 30 min on ice.
Propidium iodide staining was performed in PBS, sodium citrate 0.1%, PI 100 µg/ml at 37°C for 15
min. Analysis was performed using a FACScan cytometer (Becton Dickinson, Franklin Lakes, NJ).
Cell cycle determination after UV irradiation was performed by PI staining on cells synchronized by
incubation with 1 mM hydroxyurea during 16h.
Shuttle vector experiment
7The SV40-based shuttle vector pR2 carries the 289 bp bacterial lacZ' gene and promoter as
mutagenesis target, the kanamycin resistance gene, and the SV40 and bacterial replication origins
[22]. The pLAS plasmid carries the SV40 T-antigen gene, which is required for replication of the pR2
plasmid. Both vectors were co-transfected by electroporation. After 4 days, all plasmids were
recovered using Qiaquick miniprep kit (Qiagen, Valencia, CA), and then digested with DpnI (New
England Biolabs, Beverly, MA) to eliminate unreplicated plasmids. The TOP10 E. coli strain
(Invitrogen) was used for the blue / white screening of lacZ' mutants. The pR2 plasmid was irradiated
using a Stratalinker 2400 (Stratagene) at 3.5 kJ/m_ at a fluence rate of 25 J/m_/s.
Sequencing was realized on an ABI 3100 sequencer (Applied Biosystems, Foster City, CA) using
forward primer: TCGAACACCGAGCGACCCTG.
Hotspots positions on the promoter and coding sequence of the lacZ’ gene are considered as
statistically significant when the occurrence by chance of the observed number of mutations at a given
position, related to the total number of mutations collected and to the number of mutable target
nucleotides, falls below 1% according to the law of Poisson. For this determination, double close
mutations were excluded. Significant hotspots are shown in fig. 6 while total mutations scored are
shown in supplementary fig. 3.
Western blot
300 µg of protein were fractionated by SDS PAGE using 10% polyacrylamide gels and transferred on
a PVDF Immun-blot™ membrane (Biorad, Hercules, CA). Primary and secondary antibodies were
diluted in PBS, Tween 0.02% supplemented with 2.5% BSA and 2.5% dry milk. Polyclonal anti-
human Pol η H-300 sc-5592 (1/3000 diluted from Santa Cruz Biotechnology, Santa Cruz, CA), the
polyclonal anti-human Pol ι ab1324 (1/4000 diluted from Abcam, Cambridge, UK), the monoclonal
anti-PCNA PC10 (1/5000 diluted from Santa Cruz) and the monoclonal anti-c-myc 9E10 sc-40 (1/150
diluted from Santa Cruz) were used. Anti-mouse IgG 170-6516 and anti-rabbit IgG 170-6515
(Biorad), both of them diluted 1/10000, were used as secondary antibodies. Chemoluminescent
revelation was made with Westpico ECL (Pierce, Rockford, IL). PCNA ubiquitination was analyzed
by SDS PAGE using a 12% polyacrylamide gel and loaded with the triton insoluble fraction. Cells
were incubated for 30 sec. in a 1% Triton X-100 PBS and centrifugated, the pellet was subsequently
resuspended and sonicated in the loading buffer.
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Generation of the polymerase-deficient BL2 cell lines.
Inactivation of the POLI gene by homologous recombination in the BL2 cell line has already
been described [23]. Two independent clones have been obtained (clones 54 and 267) after successive
inactivation of the two alleles. The same strategy was used to inactivate the POLH and REV3L genes.
POLH-/- cell line
The POLH gene was inactivated by replacing exons 2 and 3 by antibiotic resistance genes
(fig.1A); exon 2 contains the ATG initiator codon and one of the 5 conserved motifs (DMD) whose
mutation abolishes the catalytic activity of yeast Pol η [24]. During the course of this inactivation we
observed that the wild-type BL2 cell line has three copies of the POLH gene. Although aneuploidies
are a common feature of transformed cell lines, a FISH analysis with probes covering over 100 kb of
POLH failed to reveal any large duplication of the POLH locus (data not shown). This small proximal
duplication may thus represent a physiological event, as small deletions and duplications have been
shown recently to occur rather frequently during normal meiosis [25]. The same constructs with
different selection markers were used to inactivate the three alleles. They carry the hygromycin,
histidinol and zeocine resistance genes within the POLH locus. Three knockout clones, named
123.12, 82.80 and 82.120 in the experiments shown, were derived from two independent
heterozygous clones with a -/-/+ genotype (82 and 123). POLH inactivation was checked by western
blot in each of these clones (suppl. fig.1A). Throughout this study, the Pol η-deficient clones are
named POLH-/- for sake of simplicity.
REV3L-/- cell line
We followed the same strategy as the one used by Esposito et al. [15] which resulted in
embryonic lethality in mice, i.e. by replacing exon 5 encoding the ATG initiator codon by resistance
cassettes (fig.1B). We inactivated the first allele by deleting 5 kb including exons 5 and 6 and the
second allele by deleting 100 bp including exon 5. Two REV3L +/- clones were obtained and one
knockout clone was derived from each heterozygous cell, named 332 and 504 thereafter.
9As no human anti-REV3L antibody is available, we checked for the absence of the 5’ part of
the mRNA in the two clones obtained (suppl. fig. 1B). Moreover, the severity of the phenotype
observed on these two independent clones (see below) appears as a good indicator of REV3L
inactivation.
POLH-/- POLI-/- cell line
We used the same constructs containing histidinol and zeocin resistance genes as the ones
used for POLH inactivation, and replaced the hygromycin resistance marker by blasticidine in the
third construct to transfect the POLI-/- clone 54 (see fig.1A). A single POLH-/- POLI-/- clone was
generated in which the inactivation of POLH was checked by western blot analysis (supplementary
fig.1A).
Characterization of Pol η, Pol ι, Pol η/ι and REV3L-deficient cell lines
The doubling time of exponentially growing cell cultures was checked for each cell line. A
slight increase in doubling time for the two single POLH-/- or POLI-/- clones (22h instead of 20h) was
reproducibly observed (+/- 30 min), and a more pronounced increase for the POLH-/- POLI-/- clone
(24h instead of 20h). REV3L-/- clones showed the largest increase in doubling time (29h).
Cell cycle analysis was performed after 3h of bromodeoxyuridine (BrdU) uptake using
propidium iodide and anti-BrdU staining. A similar distribution between the various phases of the cell
cycle was observed for the POLH-/-, POLI-/-, POLH-/- POLI -/- and wild-type cell lines (shown for
POLH-/- cells in fig. 2A). On the contrary the REV3L-deficient clones showed a strong accumulation
of cells in the G2/M phase (fig. 2A). Furthermore, these clones show increased chromosome
abnormalities including breaks, translocations and polyploidy (not shown).
Killing by UV is increased in POLH -/- POLI -/- and REV3L-/- cell lines
The UV-induced cytotoxicity in mutant cell lines was evaluated by their sensitivity to UVC
(254 nm) and UVB (312 nm). Similar results were obtained for both wavelengths. POLH-/- cells were
more sensitive than wild-type cells for both UV wavelengths (a 2-fold decrease in the D90 UV dose,
achieving 90% cell mortality, fig. 3A, B & C). The UV sensitivity was not altered when these
experiments were repeated with cells cultured in the presence of caffeine (data not shown). This result
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was surprising since caffeine is known to exacerbate the sensitivity of human XPV fibroblasts to
killing by UV [26]. However a caffeine-independent UV sensitivity has also been reported in chicken
DT40 Pol η-deficient cells in which the P53 pathway is similarly inactive [27]. A full restoration of
the resistance to UV light was obtained in two POLH-/- clones in which an expression vector encoding
an EGFP-Pol η fusion protein was stably transfected (not shown). In parallel, the over-expression of
Pol η in wild-type cells (more than 25-fold, see suppl. fig. 2), using tetracycline inducible expression
vectors did not modify the resistance to UVB light (fig. 3C).
The POLI-/- was not UV sensitive, the survival curves being strictly identical to wild-type cells
for both clones and both wavelengths. However BL2 cells deprived of both Pol η and Pol ι showed a
higher sensitivity to UV-induced killing when compared to POLH-/- clones (a 1.6-fold decrease for the
D90 value, fig. 3A). The inactivation of the REV3L gene in BL2 cell line led for both clones to the
most drastic effect on UV-induced killing in all experiments, resulting in an increase in UV sensitivity
of 10-fold when compared to wild-type cells (fig. 3A).
Analysis of the cell cycle after UV irradiation was performed in cells synchronized by
incubation with 1 mM hydroxyurea. Sixteen hours after hydroxyurea addition, cells were UV-
irradiated at 0.5, 2 or 4 J/m_ for R E V 3 L-/-, POLH -/- and wild-type cell lines respectively (an
approximate D90 dose, allowing their comparison in similar conditions of UV-induced killing). Cell
cycle was analyzed 24 h after irradiation by propidium iodide staining. The cell cycle was very
differently affected: POLH -/- cells were predominantly blocked during their replication in the early S-
phase of the cell cycle while REV3L -/- cells were largely blocked in a later S or early G2-phase (fig.
2B). Similar observations were made in asynchronous populations (Fig. 2A).
UV-dependent localization of EGFP-Pol η in POLI-/- and REV3L-/- cell lines.
Pol η has been shown to accumulate at DNA damage foci that form upon induction of
replication blocking lesions. In XPV cells transiently transfected with EGFP-Pol η, the proportion of
foci positive cells was largely increased after UV irradiation [28] We transfected an EGFP-Pol η
construct in wild-type, Pol ι-deficient or REV3L-deficient cell lines. A stable transfection was
preferred to a transient one to avoid the transfection stress and the risk of non physiological
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expression. The different clones with the same genotype behaved similarly and the number of foci-
positive cells reached a maximum 10h after irradiation (fig. 4A).
As shown in fig. 4B, the proportion of cells presenting spontaneous or UV-induced foci was
largely increased on a REV3L-deficient background when compared to wild-type cells. This indicates
that, in the absence of REV3L, Pol η accumulates at sites of endogenous DNA damage, the nature of
which remains to be identified. Moreover it has been shown that Pol ι fails to accumulate efficiently
at replication foci in Pol η-deficient cells [17]. In contrast, we observed that the absence of Pol ι had
no impact on Pol η accumulation at replication foci after UV treatment.
The Pol η-deficient clone 123.12 was transfected with an EGFP-Pol η expression vector in
which the PIP-box motif of the PCNA interacting domain was mutated: the four conserved amino
acids within this motif at position 702-708 being mutated to alanines: QTLESFF [28, 29]. The
transfected gene was expressed at a level comparable to wild-type in the 2 stable clones obtained
(supplementary fig. 2 for the PIP-box mutant). The expression of the PIP-box mutant restored full UV
resistance in these two clones (fig. 3B). However, they showed no replication foci 12h after UV
irradiation (fig. 4A and 4B), thus indicating that functional complementation and accumulation at
replication foci can be dissociated.
Mutant rate on UV-irradiated shuttle vector
The shuttle vector (pR2) is an SV40-based replicative plasmid, which contains the lacZ’
target gene. It is cotransfected in BL2 cells with the pLAS vector, allowing the expression of SV40 T
antigen, which is necessary for the bidirectional replication of pR2 from its SV40 origin of
replication. The shuttle vector was irradiated in vitro with 3 kJ/m2 of UVC and immediately
cotransfected with pLAS in BL2. After 4 days, plasmids were collected and digested with DpnI in
order to eliminate non replicated copies. The digested DNA was transformed in E.coli and mutant rate
at the lacZ’ locus was determined using alpha-complementation (fig. 5). The spontaneous mutant rate
on non-irradiated plasmids was below 0.7x10-3 with no significant differences observed between the
cell lines. The shuttle experiment using irradiated plasmids was repeated at least three times in the
different clones available for each cell line. As different clones with same genotype gave similar
results, data were pooled.
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In the two POLH-/- clones, mutagenesis induced by UVC was increased 1.5-fold compared to
wild-type, as shown in fig. 5 (P<0.05 with Student test). The Pol ι deficiency had no impact on the
mutant frequencies, whether on a Pol η proficient or-deficient background. On the contrary, the lack
of REV3L decreased considerably the mutant rate on both clones (from 3.3 to 0.7%), but remained
10-fold higher than the spontaneous mutant rate (fig. 5).
Pattern of mutations induced by UV lesions
Table I summarizes mutations induced on the lacZ’ gene after replication of UV-irradiated
vector in the different polymerase-deficient cell lines. A total of 1246 mutations were collected, with
only independent mutations being taken in consideration (suppl. fig. 3). Statistically significant
differences, as determined by χ2 tests, are marked in bold style in table I and are discussed below.
Point and tandems mutations:
UVC produced predominantly single base pair substitutions at pyrimidine dinucleotides sites
in all the cell lines. As expected from the known mutagenic action of UV irradiation in vivo, most of
the mutations were C to T transition events [30].
Misincorporations opposite the 3’ position of TT sites were increased in both POLH-/- and
POLH-/- POLI-/- cell lines, 39% and 32% respectively vs. 25% in wild-type. In contrast, the level of
mutations at the 5’position of TT sites was significantly reduced (2% or less) in these cell lines
compared to wild-type (6%), suggesting that Pol η might be occasionally mutagenic opposite the 5’
position of  TT sites.
The remaining mutations in the REV3L-/- background were mainly C to T transitions (89% vs.
42% in wild-type) occurring at the 3’ position of TC and CC sites, with a shift in hotspot profile (see
below). Strikingly, an increase in tandem CC to TT mutations (13% vs. 3%) was also noted in these
cells. In parallel there was a drastic drop of mutations at the 3’ position of TT (3% vs. 25% in wild-
type) and CT sites (2% vs. 8 % in wild-type), showing clearly that Pol ζ is directly involved in
misincorporations opposite UV damages containing thymines.
Double close mutations:
Some more complex mutations corresponding to two point mutations spaced by one correct
base were frequently observed. The level of these “double close” mutations increased significantly in
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POLH-/-, POLI-/- and POLH-/- POLI-/- clones relative to the wild-type cell line. Interestingly, the wild-
type nucleotide located between the two mutations was predominantly a thymidine residue, indicating
that double close mutations arose from an error-prone bypass event in a 5’NTPy3’ context (mutated
nucleotides underlined). These mutations were completely absent in the REV3L-/- cell line indicating
that these mutations are strictly REV3L-dependent.
Spectra of hotspot positions
Hotspots were determined according to the Poisson law, as described in materials and
methods. Briefly, the position was considered as a hotspot if the amount of mutations at a given
position was at least 4-fold above what a pure random mutagenesis would produce. When related to
the mutation pool analyzed for each cell type, this represented 5 mutations for the wild-type, POLI-/-
and POLH-/- POLI-/- cell lines, 7 for the POLH-/-, and 4 for the REV3L-/- cell lines. The hotspots
profiles for each cell line are shown in figure 6. All mutations scored are shown in supplementary
figure 4.
Six additional hotspots occurred in the POLH-/- mutation spectrum (-38, 13, 43, 67, 68, 112)
as compared to the wild-type profile, thus representing sites of UV damage for which the error-free
bypass was strictly dependent on Pol η (fig. 6). Five of these hotspots disappeared in the POLH-/-
POLI-/- mutation spectrum (-38, 13, 67, 68, 112), thus making likely that Pol ι is responsible for this
mutagenic bypass in the absence of Pol η. These mutations were concentrated on TT dinucleotides in
a 5’ PuPyPyPu 3’context (3 out of 5, positions 13, 68 and 112), and notably for two of them in a
5’ATTA3’sequence. It has been demonstrated by in vitro TLS assays using purified proteins that Pol ι
can catalyze error-prone bypass of TT CPDs located in such a 5’ATTA 3’ sequence context [9].
Moreover, the mutation pattern of these 5 hotspots exhibited a higher frequency of transversions than
the rest of the mutations (63% vs. 37%, p=0.0013, χ2 test). For the position 43 hotspot, a polymerase
other than Pol ι appears to be involved in mutagenesis when Pol η is absent, while error-free bypass
requires Pol ζ.
In the REV3L-/- mutant background, cytosines were more targeted as evidenced by the
presence of C targeted hotspots unique to this cell line at positions -69, 40, 76, 95 and 107.
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Symmetrically, thymines were less targeted: three hotspots located on TT sites (positions 32, 73, and
98) were present in all but the REV3L-/- profile (fig. 6).
Complex mutations involving multiple TLS specificities
At position 71, 92 and 97, Pol η was mutagenic either alone (position 92) or in cooperation
with REV3L (positions 71 and 97). In their absence, Pol ι alone could be used as an anti-mutagenic
backup, since these hotspots were missing when Pol ι was expressed (fig. 6). A similar explanation
applies to the hotspot at position -11, with the difference that, in the absence of both Pol η and Pol ι,
error-prone bypass by a third polymerase (unknown) appears to take place. At position 127, a hotspot
arose in the POLI-/- and the REV3L-/- spectra, suggesting that an error-free TLS was performed by the
combined action of these two polymerases in wild-type cells. Finally, at position 47, a hotspot
occurred in a POLI-/- and not in the double Pol η  / Pol ι-deficient background implying that a
mutagenic bypass by Pol η occurred in the absence of Pol ι. In all these cases, TLS could be aborted
when Pol ι and Pol η are not present, since these hotspots were absent from the POLI-/- POLH-/-
spectrum. Finally, hotspot mutations were observed at positions 31 and 80 in the double Pol η / Pol ι-
deficient spectrum, suggesting that the simultaneous absence of these polymerases result in an error-
prone bypass that does not require Pol ζ.
DISCUSSION
Human cell lines deficient in Pol η and Pol ι, either singly or in combination, or in REV3L,
the catalytic subunit of Pol ζ, have been obtained by targeted inactivation of the corresponding genes,
thus allowing for the first time the direct comparison of their respective phenotype in the same genetic
background, the BL2 Burkitt's lymphoma.
The different deficient cell lines behaved differently when tested for their exponential growth
and UV resistance. A slight increase in the doubling time was observed for the POLH-/- or the POLI-/-
cell lines (22h instead of 20h), this increase being accentuated in the double deficient cell line (24h).
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The growth retardation was still more pronounced in REV3L-/- cells with a doubling time of 29 h. This
increase may be due to an increased cell loss by spontaneous cell death.
The Pol η-deficient clones were less resistant to UV irradiation than wild-type cells, while the
POLI-/- cell line did not show any specific UV sensitivity. However BL2 cells deprived of both Pol η
and Pol ι showed a marked increased sensitivity as compared to the Pol η-deficient cell line. It has
been shown that adult fibroblasts derived from a Pol ι or a Pol ι/Pol η-deficient mouse were slightly
more sensitive than their Pol ι proficient counterparts [19] but such an observation was not confirmed
in MEF derived from a similar double deficient mouse [20]. The complete absence of the REV3L
protein in the BL2 cell line led to the most drastic effect of UV-induced killing, resulting in a 7-fold
increase in UV-sensitivity (estimated by the D90 values). Such an increased sensitivity after UV
irradiation has been previously observed in a Rev3L-deficient mouse fibroblast cell line [31].
The analysis of the cell cycle after a mild irradiation revealed that the block in cell cycle
progression occurred in late S or G2/M in REV3L-/- cell lines instead of early S for POLH-/- clones. In
agreement with these results, XPV fibroblasts have been shown to be delayed in post-replicative
repair after UV irradiation [26] whereas the REV3-deficient DT40 cell line was not [13]. A model for
TLS has been recently re-actualized, based on bacterial and yeast data [32], proposing that replication
can restart before complete lesion bypass is achieved, leaving gaps of single stranded DNA
downstream the damaged DNA. Translating this model to higher eukaryotes, one could propose that
Pol ζ would be required for sealing those gaps left by such replication restart process. The block in
early-S cell cycle phase observed in Pol η-deficient cells after UV irradiation would suggest that
replication restart could be conditioned by the initiation of lesion bypass. This proposition, obviously
speculative, is detailed in supplementary figure 4.
A shuttle vector containing the lacZ’ target gene and an SV40 origin of replication was
transfected after irradiation in the different BL2 cell lines. The mutant rate of replicated plasmids
determined at the lacZ’ locus was increased by a factor of 1.5 in the Pol η-deficient cell lines as
compared to wild-type cells. Increase in mutagenesis was similar in the double Pol η/Pol ι mutant cell
line, but was not observed in the Pol ι only deficient background. In agreement with other
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mutagenesis assays performed on chromosomal genes, there was a 4-fold drop in the frequency of
mutations in the shuttle vector transfected in the two REV3L-deficient clones.
The shuttle approach allows the collection and analysis of large mutation datasets. Its inherent
drawback lies in the partial chromatinization of the TLS substrate. Moreover, in these experiments,
cells were not pre-irradiated prior to transfection of the shuttle vector. Nevertheless, the constitutive
level of PCNA mono-ubiquitination observed in the BL2 cell line (our unpublished data) suggests that
proper TLS complex may be assembled even in the absence of prior UV-irradiation of the transfected
cells.
The large number of mutations collected in the present study allowed a detailed analysis of
UV-induced mutations through the identification of hotspot positions whose occurrence reaches
statistical significance. Some of these hotspots emerged in specific polymerase-deficient contexts,
implying, along with the in vitro data, an in vivo bypass specificity for each of these polymerases.
Five specific mutation hotspots were only observed in the Pol η-deficient cell lines. These
mutations, which disappeared in the Pol η/Pol ι-deficient cell line, were concentrated on TT sites (3
out of 5), and may thus be due to a back-up mutagenic bypass of TT CPDs by Pol ι [8, 19, 20, 33].
These hotspots show a specific mutation pattern with a predominant occurrence of transversions, in
agreement with the mutation pattern of the HPRT gene observed in UV-irradiated fibroblasts of XPV
patients and Pol η-deficient mice [19, 34]. However, we did not observe, after transfection of the
shuttle vector in our POLH-/-POLI-/- deficient cell line, the drop in mutation frequency described at the
HPRT locus in two recent reports in which pol ι expression was either inactivated (mouse adult
fibroblasts [19]), or simply reduced by anti-sense inhibition (transformed XPV fibroblasts) in a pol η-
deficient context [33]. These differences are likely to reflect differences between irradiated episomal
vectors and endogenous genes, or possibly between the cell type studied (lymphocytes vs. fibroblasts).
Interestingly, three hotspots of mutation observed in the Pol ι deficient background suggest in contrast
an anti-mutagenic lesion bypass activity of Pol ι.
In the absence of REV3L there was a marked drop in mutant frequency, indicating that about
4/5 of mutations found in wild-type cells are linked to Pol ζ activity. The remaining mutation pattern
consisted mainly in C to T transitions targeted at the 3’ C of TC and CC sites, and was correlated with
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the presence of five hotspot positions unique to this cell line. A possible explanation for these
mutations could be that replication over TC and CC photolesions may require Pol ζ as a bypass
extender. In its absence, the slowing down of the process would result in an increase in cytosine
deamination within photolesions, allowing for an unassisted synthesis in this new sequence
configuration (TU or UU dimers) [35, 36]. This may explain how for example Pol η, which formed
abundant UV-induced nuclear foci in the Pol ζ-deficient cell line (and also in the Pol ι-deficient cell
line), could become mutagenic on such C-containing photolesions. Such a sequence of deamination
events has been postulated to explain the P53 mutational pattern of C to T mutations within CPDs
lesions in solar-induced human skin cancers [30]. Conversely mutations at the 3’ T of TT and CT sites
dropped considerably in the absence of REV3L, suggesting that such lesions could not be copied
without Pol ζ. Accordingly, there were three mutation hotspots on TT dimers present in all cell lines
at the exception of the Pol ζ-deficient one, pointing toward a role for Pol ζ, either alone or in
association with another polymerase, in order to bypass these lesions.
There were again differences between the mutation pattern observed on the shuttle vector
described in this study and the ones that have been scored at the HPRT locus in cell lines in which
REV3L expression was reduced by an antisense transgene. However, in the two assays using anti-
sense inhibition of REV3L expression in either mouse [37] or human fibroblasts [12], no UV-
sensitivity was induced, in marked contrast to all other cases (mouse fibroblasts, DT40 and BL2) in
which gene knock-out was performed, thus putting in question whether the impact of REV3L
inactivation was really assessed.
While it has been shown that Pol ι does not efficiently participate in UV-induced nuclear foci
in the absence of Pol η  [17], our data and the ones published by other groups [19, 20, 33] tend
nevertheless to indicate that Pol ι alone can be involved in damage tolerance at the replication fork.
PCNA is mono-ubiquitinated in human cells after UV irradiation and it has been shown that this
modification mediates its interaction with Pol η [38, 39]. Accordingly, Pol η and Pol ι only bind to
mono-ubiquitinated PCNA. This binding occurs through two types of motifs, a PCNA interacting
peptide (PIP-box motif), which binds directly to PCNA and provides the specificity of the reaction,
and ubiquitin binding motifs (UBDs), which are strictly required for their accumulation at replication
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factories [40]. Effectively, it has been reported that a Pol η PIP-box mutant could complement,
although partially [40], the UV survival defect of an XPV fibroblast. Not only could we observe a
complete restoration of UV resistance when the BL2 Pol η-deficient cell line was transfected with a
Pol η PIP-box mutant but, much to our surprise, no UV-induced nuclear foci could be observed in this
complemented cell line. These results on the UV resistance provided in a Pol η-deficient background
by either Pol ι or a Pol η PIP-box mutant support the notion that TLS polymerases can be recruited at
replication factories without the formation of observable UV-induced replication foci, the difference
lying probably in their capacity to accumulate at sites of DNA damages beyond a detectable
threshold.
Altogether these data strengthen, in a complete K.O. human model, the suggestion that Pol ι
is involved in error-prone bypass of UV-induced lesions in the absence of Pol η, while also, and more
surprisingly, being capable of error-free bypass in specific sequence contexts. These data also
reinforce the notion that Pol ζ is a key partner in UV resistance and in the bypass of specific lesions,
but also that this polymerase may be crucial for the maintenance of genome integrity during post-
replicative repair. Moreover, the pattern of UV-induced mutations observed in the absence of Pol ζ
with our shuttle vector strikingly mirrors the mutations observed in the TP53 gene from skin tumors
which similarly display a strong C to T transition bias.
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FIGURE LEGENDS:
Fig. 1: Scheme of the homologous recombination strategy used to inactivate the POLH (A) or the
REV3L gene (B).
Non coding exons are indicated in white rectangles and coding exons in black rectangles, with
resistance cassette not drawn at scale. The POLH locus extends over 39.5 kbp and REV3L over 184
kbp. Scale bars are 5 kbp wide. (a): constructs used to inactivate POLH in the wild-type BL2 cell line.
(b): constructs used to inactivate POLH in a POLI -/- cell line. Resistance names written upside down
are in reverse orientation compared to the loci.
Fig. 2: Cell cycle analysis in polymerase-deficient cell lines.
A) Cell cycle analysis of UV-irradiated and control cells. Cells were incubated during 4 h with BrdU
prior to analysis with propidium iodide and anti-BrdU antibody staining. The analysis was performed
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on unirradiated cells (upper panel) or 20h after UV irradiation corresponding to the D90 value of each
cell line (lower panel). B) Cell cycle analysis of synchronized wt, Pol η and Pol ζ-deficient cells after
UV irradiation. Cells were synchronized in early S phase by 16 h incubation with 1 mM hydroxyurea.
Cells were UV-irradiated immediately after drug removal with doses corresponding to D90 values
(given in the legend of the fig. 3), and their cell cycle analyzed 24 h later by propidium iodide
staining.
Fig. 3: Survival of cell lines exposed to UV light.
Survival is expressed in percentage of non-irradiated control.
A) UV sensitivity of the WT, POLH -/-, POLI -/-, double deficient and REV3L-/- cell lines. All cell lines
were irradiated simultaneously. B) Restoration of UV resistance in a Pol η-deficient clone by
expression of an EGFP Pol η PIP-box mutant. C) Restoration of UV resistance in a Pol η-deficient
clone by wt EGFP Pol η overexpression. A, B) UVC irradiation. C) UVB irradiation. D90 doses
(J/m_ UVC): 4.22±0.38 for WT cells, calculated on the basis of n=10 experiments; 2.05±0.35 for Pol
η-deficient cells (n=23); 4.1±0.4 for Pol ι-deficient cells (n=7); 1.27±0.28 for Pol η Pol ι-deficient
cells (n=15); 0.42±0.2 for REV3L-deficient cells (n= 8).
Fig. 4: Accumulation of EGFP-Pol η in replication foci.
EGFP-Pol η was stably expressed in wt, Pol ι and REV3L-deficient cell lines and an EGFP-Pol η
PIP-box mutant was stably expressed in the Pol η-deficient cell line. A) Representative confocal
images of BL2 polymerase-deficient cell lines with or without UV irradiation (10 J/m_ of UVC).
B) Proportion of EGFP-Pol η foci-positive cells in different polymerase-deficient backgrounds. Mean
values and range of three independent experiments are represented.
Fig. 5: Mutant frequencies of the lacZ’ gene of the UV-irradiated shuttle vector.
Frequencies are calculated by the proportion of light blue / white colonies relative to dark blue ones
after transformation in E.coli. Each mutant was checked by sequencing. Mean value and error bars of
3 independent experiments are represented for each cell line.
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Fig. 6: Hotspot positions along the lacZ’ gene of the UV-irradiated shuttle vector.
Numbers refer to the lacZ’ sequence with 1 being the ATG initiator codon. Only hotspots that reached
a statistically significant threshold are shown (see definition in Materials and Methods). The complete
representation of collected mutations is shown in supplementary fig.4. The red bars indicate hotspots
restricted to specific polymerase contexts. Blue arrows indicate a position where a specific hotspot is
missing. In both cases, these hotspots are written within a 5 nucleotide sequence context with the
mutated nucleotide underlined. The peak height is proportional to the percentage of hotspot mutations
at any given position (the bar scale represents 10 % of hotspot mutations).
Supplementary fig. 1: Control of POLH, POLI and REV3L inactivation.
A) POLH-/- and POLI-/-POLH-/- cell lines were checked by western blot for the absence of the Pol η.
B) The absence of REV3L mRNA in the two REV3L-/- clones was checked by RT-PCR.
Supplementary fig. 2: Pol η expression during the PIP-box mutant restoration experiment (lane 6) and
the overexpression experiment in wt cells (lane 8). PCNA is used for normalization.
Supplementary fig. 3: Distribution of all scored mutations along the lacZ’ target gene.
Tandem mutations are highlighted in yellow, ‘’double close’’ mutations are highlighted in red.
Insertions are marked with a (+) over the previous nucleotide and deletions are indicated by dashes.
Numbering refers to the sequence of the lacZ’, 1 being the first base of the ATG initiator codon.
Supplementary fig. 4: A hypothetical scheme for a replication restart model involving pol ζ in a gap
filling process.
Replication restart would occur when the replication fork encounters UV damage in the wt and
REV3L-/- context, allowing the cell to proceed up to the G2 phase and to perform post-replicative
repair (PRR) as monitored by 3H-thymidine pulse-chase labeling (in blue on the scheme). Filling of
gaps left behind the replication fork would be performed or initiated by Pol ζ (in green). REV3L-/-
cells would be accordingly blocked in G2. No replication restart would occur in Pol η-deficient cells,
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which are blocked in early S and show delayed PRR, thus implying that replication restart might be
conditioned to the engagement of Pol η opposite the UV lesion (in red).
Table I: Mutation profile of the irradiated shuttle vector after replication in the various polymerase-
deficient cell lines.




 Number of clones  2 2 1 2
 Number of experiments 4 7 4 4 6
Single substitutions 79 80 77 82 82
CC to TT tandems 4 2 3 3 13*
Other tandems 12 8 8 7 1**
Double close 3 9** 9** 7* 0




Deletions 1 0 0 0 1
C to T 42 40 47 43 89***
C to A 11 9 9 11 1***
C to G 4 2 5 1 3
T to C 17 20 16 19 6**





T to G 7 6 6 10 1***
TT 3' 25 39** 25 32 3**
TC 3' 40 38 31 37 59
CT 3' 8 6 10 9 2
CC 3' 15 9 14 13 22
 
5'TT 6 2* 6 1* 3
5'TC 1 0 1 1 0
5'CT 2 1 1 2 6




Non di-pyrimidic 4 4 10* 4 6
All values are expressed in percentage of the total number of mutations indicated at the bottom of each section.
TT 3’ indicates that the mutation occurred opposite the 3’ position of the dinucleotide. On the contrary, 5’TT
indicates that replication was error prone opposite the 5’ nucleotide. Tandem mutations are scored as 2
mutations. * marks P value <0.05, ** P<0.01 and *** P<0.001 as determined by the χ2 test. Total number of
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